08/17/2026
❤ STAGE 4 LIVER AND BRAIN CANCER TESTIMONIALS❤
DISCLAIMER : THIS POST IS FOR EDUCATIONAL PURPOSES AND TO RAISE AWARENESS ONLY.
DR YOUSUF ZAFAR'S ARTICLE ;
Patient: West Markson
Diagnosis: Stage IV metastatic gliobastoma with liver tumor
Mode of Care: Remote / Online Consultation and Protocol Delivery
The patient was initially diagnosed with stage 4 glioblastoma and liver tumor in March 2024, with the primary lesion located on the scalp. Disease progression was documented with metastasis to liver lymph nodes in April 2025 and intracranial metastases identified in October 2025.
For approximately 10 months, available management consisted primarily of surgical intervention. During this period, the patient underwent five surgical procedures, including neurosurgical intervention, addressing a total of 13 tumors involving the neck and brain. Postoperative complications included transient left-sided motor and sensory deficits lasting approximately six months, recurrent seizures over an eight-month period, and a prolonged intensive care admission that included coma and life-support measures.
Systemic chemotherapy was initiated but discontinued due to poor tolerance. Following a comprehensive online consultation, medical history review, and intake assessment, the patient began a structured remote, integrative treatment protocol under the guidance of our service followed up and directed by Dr Yousuf Zafar
The initial phase consisted of a 90-day RSO (Rick Simpson Oil) protocol, supported by dietary modifications including the elimination of alcohol and refined sugars. The protocol was delivered remotely, with ongoing email-based guidance and monitoring.
Post-protocol imaging demonstrated marked tumor regression, with findings described as inactive and non-replicative malignant cells. Based on continued observation and clinical response, the patient was subsequently transitioned to an adjunctive protocol incorporating Iv*rmectin, F*nbendazole, and M*bendazole, implemented as part of the same online treatment framework which medications delivered to the patient alongside the usage protocol manual after the order process was completed.
The patient remained under observation throughout this phase, with no documented evidence of disease progression. Follow-up assessment ultimately resulted in the patient being declared cancer-free. The total duration of RSO exposure was approximately four months, representing one of the longer continuous treatment courses of this nature documented locally.
This case reflects an early local application of a remote, integrative, protocol-based approach for Stage IV glioblastoma with brain involvement and liver tumor. Tumor response occurred gradually and after 90days of completing the protocol, scans showed zero sign of cancer or tumor present, this thus highlights the importance of adherence, individualized dosing considerations, and longitudinal monitoring within an online care model.
At the time of this report, the patient remains clinically stable with both cancer and tumor free.
PM 👉 Dr Yousuf Zafar MD PHD TO GET THE BEST ALTERNATIVE CANCER PROTOCOL.
Join our Facebook COMMUNITY at ALTERNATIVE CANCER TREATMENT(IVERMECTIN,FENBENDAZOLE & RSO OIL PROTOCOL)
⸻